版本:
中国

BRIEF-AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable

Oct 4 AstraZeneca Plc

* Executive Ludovic Helfgott tells Reuters $3.5 billion sales goal for Brilinta no longer attainable Further company coverage: (Reporting by UK bureau)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐